Shattuck Labs (STTK) holds steady as SL-325 shows strong Phase 1 data; Phase 2b Crohn’s trial starts Q3 2026. Read here for a ...
INGELHEIM, Germany & SINGAPORE--(BUSINESS WIRE)--Boehringer Ingelheim announced today that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a Phase 1 ...
(A) Schematic illustration of the synthesis process for a carbon material with controlled mesoscale porosity. (B) External view of the 1-Wh-class stacked lithium-air battery fabricated in this study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results